1)Miyazaki M, Yoshitomi H, Miyakawa S, et al:Clinical practice guidelines for the management of biliary tract cancers 2015:the 2nd English edition. J Hepatobiliary Pancreat Sci 22:249-273, 2015
2)Yamaguchi K, Okusaka T, Shimizu K, et al:EBM-based Clinical Guidelines for Pancreatic Cancer(2013)issued by the Japan Pancreas Society:a synopsis. Jpn J Clin Oncol 44:883-888, 2014
3)Valle J, Wasan H, Palmer DH, et al:Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362:1273-1281, 2010
4)Okusaka T, Nakachi K, Fukutomi A, et al:Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer:a comparative multicentre study in Japan. Br J Cancer 103:469-474, 2010
5)Kato A, Shimizu H, Ohtsuka M, et al:Downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer patients treated with gemcitabine plus cisplatin combination therapy followed by radical surgery. Ann Surg Oncol 22:1093-1099, 2015
6)Von Hoff DD, Ervin T, Arena FP, et al:Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369:1691-1703, 2013
7)白崎圭一,森川孝則,大塚英郎,他:肝門部胆管癌多発肝転移に対し肝切除およびGemcitabine,S-1療法が奏功し長期生存を得た1例.癌と化療41:1530-1532,2014
8)大道清彦,坂本裕彦,高橋 遍,他:肝切除後3年無再発生存中の膵癌肝転移の1例.日臨外会誌76:1494-1498,2015
9)藤﨑 滋,高階 幹,富田涼一,他:肝胆膵癌の肝転移に対する肝切除4例の検討.癌と化療42:1451-1453,2015
10)三島 敬,古川勝規,清水宏明,他:膵腺房細胞癌切除後の異時性肝転移に対し肝切除した1例.癌と化療42:2403-2405,2015